Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.65 EUR
−44.64 M EUR
41.61 M EUR
10.07 M
About Santhera Pharmaceuticals Holding AG
Sector
Industry
CEO
Dario Eklund
Website
Headquarters
Pratteln
Founded
1998
ISIN
CH1276028821
FIGI
BBG01TT5K8N7
Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of S3F0 is 15.20 EUR — it has increased by 2.01% in the past 24 hours. Watch Santhera Pharmaceuticals Holding AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Santhera Pharmaceuticals Holding AG stocks are traded under the ticker S3F0.
S3F0 stock has risen by 1.88% compared to the previous week, the month change is a −0.39% fall, over the last year Santhera Pharmaceuticals Holding AG has showed a 43.40% increase.
We've gathered analysts' opinions on Santhera Pharmaceuticals Holding AG future price: according to them, S3F0 price has a max estimate of 31.88 EUR and a min estimate of 25.50 EUR. Watch S3F0 chart and read a more detailed Santhera Pharmaceuticals Holding AG stock forecast: see what analysts think of Santhera Pharmaceuticals Holding AG and suggest that you do with its stocks.
S3F0 reached its all-time high on Jul 28, 2025 with the price of 16.42 EUR, and its all-time low was 7.55 EUR and was reached on Oct 11, 2023. View more price dynamics on S3F0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
S3F0 stock is 2.82% volatile and has beta coefficient of 1.18. Track Santhera Pharmaceuticals Holding AG stock price on the chart and check out the list of the most volatile stocks — is Santhera Pharmaceuticals Holding AG there?
Today Santhera Pharmaceuticals Holding AG has the market capitalization of 196.44 M, it has decreased by −0.58% over the last week.
Yes, you can track Santhera Pharmaceuticals Holding AG financials in yearly and quarterly reports right on TradingView.
Santhera Pharmaceuticals Holding AG is going to release the next earnings report on Sep 10, 2025. Keep track of upcoming events with our Earnings Calendar.
Santhera Pharmaceuticals Holding AG revenue for the last half-year amounts to 26.59 M EUR, despite the estimated figure of 26.59 M EUR. In the next half-year revenue is expected to reach 22.58 M EUR.
S3F0 net income for the last half-year is −28.41 M EUR, while the previous report showed −15.85 M EUR of net income which accounts for −79.25% change. Track more Santhera Pharmaceuticals Holding AG financial stats to get the full picture.
No, S3F0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 6, 2025, the company has 78 employees. See our rating of the largest employees — is Santhera Pharmaceuticals Holding AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Santhera Pharmaceuticals Holding AG EBITDA is −29.50 M EUR, and current EBITDA margin is −70.90%. See more stats in Santhera Pharmaceuticals Holding AG financial statements.
Like other stocks, S3F0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Santhera Pharmaceuticals Holding AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Santhera Pharmaceuticals Holding AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Santhera Pharmaceuticals Holding AG stock shows the strong buy signal. See more of Santhera Pharmaceuticals Holding AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.